(Q44579682)

4 December 2017

title

HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma (English)

1 reference

4 December 2017

1 reference

Anders Malmsten

1

1 reference

4 December 2017

Xing-Wu Shao

2

1 reference

4 December 2017

Kajsa Aperia

3

1 reference

4 December 2017

Gary E Corrigan

4

1 reference

4 December 2017

Eric Sandström

5

1 reference

4 December 2017

Clas F R Källander

6

1 reference

4 December 2017

Thomas Leitner

7

1 reference

4 December 2017

J Simon Gronowitz

8

1 reference

4 December 2017

publication date

1 November 2003

1 reference

Journal of Medical Virology

4 December 2017

published in

1 reference

4 December 2017

volume

71

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

347-359

1 reference

Most HIV-1 genetic subtypes have entered Sweden

4 December 2017

cites work

1 reference

Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).

21 January 2018

1 reference

A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes

21 January 2018

1 reference

Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors

21 January 2018

1 reference

Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant

21 January 2018

1 reference

A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity

21 January 2018

1 reference

The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation

21 January 2018

1 reference

Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious D

21 January 2018

1 reference

Performance characteristics of quantification assays for human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testing

21 January 2018

1 reference

Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural DNA.

21 January 2018

1 reference

Subtype-specific problems with quantification of plasma HIV-1 RNA

21 January 2018

1 reference

Performance of Five Different Assays for the Quantification of Viral Load in Persons Infected With Various Subtypes of HIV-1

21 January 2018

1 reference

Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains

21 January 2018

1 reference

Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma

21 January 2018

1 reference

Measurement of human immunodeficiency virus type 1 plasma virus load based on reverse transcriptase (RT) activity: evidence of variabilities in levels of virion-associated RT.

21 January 2018

1 reference

HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies, HIV antigenemia and clinical variables

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.10492

1 reference

4 December 2017

1 reference